Novartis subsidiary Sandoz launched a generic challenger to AbbVie’s Combigan on Thursday. The debut came less than two weeks after the FDA approved the generic ophthalmic solution. Its arrival marks ...
NEW YORK, Oct 31 (Reuters) - Allergan Inc on Wednesday said U.S. regulators approved its glaucoma drug Combigan, an eye drop which treats the potentially blinding eye condition with two drugs that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results